 Mass High Tech | Rienso(R) (Ferumoxytol) Receives European Marketing ... MarketWatch (press release) Rienso(R) (Ferumoxytol) Receives European Marketing Authorization for the Treatment of Iron Deficiency Anemia in Adult Patients with Chronic Kidney Disease ... AMAG gets European approval, $15M milestone payment Rienso® (Ferumoxytol) Receives European Marketing Authorization ... AMAG Pharmaceuticals (AMAG): IDA Therapy Gets European ... |
